Donald L. Hagan LLC Reduces Holdings in Amdocs Limited (NASDAQ:DOX)

Donald L. Hagan LLC lowered its position in shares of Amdocs Limited (NASDAQ:DOX) by 0.9% during the fourth quarter, Holdings Channel reports. The fund owned 18,115 shares of the technology company’s stock after selling 160 shares during the quarter. Amdocs makes up approximately 0.9% of Donald L. Hagan LLC’s investment portfolio, making the stock its 23rd biggest position. Donald L. Hagan LLC’s holdings in Amdocs were worth $1,592,000 at the end of the most recent reporting period.

A number of other hedge funds have also recently bought and sold shares of the company. Blue Trust Inc. boosted its position in Amdocs by 17.9% during the fourth quarter. Blue Trust Inc. now owns 1,418 shares of the technology company’s stock worth $119,000 after acquiring an additional 215 shares during the last quarter. Raymond James Financial Services Advisors Inc. boosted its holdings in shares of Amdocs by 22.6% in the 4th quarter. Raymond James Financial Services Advisors Inc. now owns 6,862 shares of the technology company’s stock valued at $603,000 after purchasing an additional 1,263 shares during the last quarter. Financiere des Professionnels Fonds d investissement inc. boosted its holdings in shares of Amdocs by 1.3% in the 4th quarter. Financiere des Professionnels Fonds d investissement inc. now owns 9,790 shares of the technology company’s stock valued at $860,000 after purchasing an additional 130 shares during the last quarter. Legato Capital Management LLC acquired a new position in shares of Amdocs in the 4th quarter valued at $2,260,000. Finally, SG Americas Securities LLC boosted its holdings in shares of Amdocs by 487.1% in the 4th quarter. SG Americas Securities LLC now owns 32,266 shares of the technology company’s stock valued at $2,836,000 after purchasing an additional 26,770 shares during the last quarter. Institutional investors and hedge funds own 92.02% of the company’s stock.

Amdocs Stock Up 0.5 %

Shares of DOX traded up $0.47 during midday trading on Friday, hitting $90.37. The company had a trading volume of 408,524 shares, compared to its average volume of 742,461. The company’s 50 day moving average price is $91.51 and its 200 day moving average price is $87.14. The stock has a market cap of $10.62 billion, a price-to-earnings ratio of 19.35, a PEG ratio of 1.46 and a beta of 0.69. Amdocs Limited has a 52 week low of $78.38 and a 52 week high of $99.75. The company has a quick ratio of 1.29, a current ratio of 1.29 and a debt-to-equity ratio of 0.21.

Amdocs (NASDAQ:DOX) last released its earnings results on Tuesday, February 6th. The technology company reported $1.56 earnings per share for the quarter, topping the consensus estimate of $1.40 by $0.16. The company had revenue of $1.25 billion during the quarter, compared to the consensus estimate of $1.24 billion. Amdocs had a net margin of 11.30% and a return on equity of 17.79%. The company’s revenue was up 5.0% on a year-over-year basis. During the same quarter in the previous year, the firm earned $1.33 EPS. On average, equities research analysts predict that Amdocs Limited will post 5.87 EPS for the current year.

Amdocs Increases Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, April 26th. Investors of record on Friday, March 29th will be given a dividend of $0.479 per share. The ex-dividend date is Wednesday, March 27th. This represents a $1.92 dividend on an annualized basis and a yield of 2.12%. This is a positive change from Amdocs’s previous quarterly dividend of $0.44. Amdocs’s payout ratio is currently 40.90%.

Analyst Ratings Changes

A number of equities analysts have weighed in on the stock. Jefferies Financial Group assumed coverage on shares of Amdocs in a report on Friday, December 1st. They issued a “buy” rating and a $105.00 price target on the stock. Barclays lifted their target price on shares of Amdocs from $105.00 to $115.00 and gave the company an “overweight” rating in a report on Thursday, February 8th. StockNews.com lowered shares of Amdocs from a “strong-buy” rating to a “buy” rating in a report on Friday, March 15th. Finally, Citigroup lifted their target price on shares of Amdocs from $96.00 to $104.00 and gave the company a “buy” rating in a report on Wednesday, January 17th. Five investment analysts have rated the stock with a buy rating, According to MarketBeat.com, Amdocs currently has a consensus rating of “Buy” and an average price target of $108.60.

Amdocs Profile

Amdocs Limited, through its subsidiaries, provides software and services worldwide. It designs, develops, operates, implements, supports, and markets open and modular cloud portfolio. The company provides CES23, a 5G and cloud-native microservices-based market-leading customer experience suite, that enables service providers to build, deliver, and monetize advanced services; Amdocs Subscription Marketplace, a software-as-a-service-based platform that includes an expansive network of pre-integrated digital services, such as media, gaming, eLearning, sports, and retail to security and business services; the monetization suite for charging, billing, policy, and revenue management; Intelligent networking suite with a set of modular, flexible, and open service lifecycle management capabilities for network automation journeys; amAIz, a telco GenAI framework; Amdocs Digital Brands Suite, a pre-integrated digital business suite; and Amdocs eSIM Cloud for service providers.